Neutralization against BA.2.75.2, BQ.1.1, and XBB from mRNA Bivalent Booster
Meredith E. Davis-Gardner, Lilin Lai, Bushra Wali, Hady Samaha, D. Solis, Matthew Lee, Andrea Porter-Morrison, Ian Hentenaar, Fumiko Yamamoto, Sucheta Godbole, Yuan Liu, Daniel C. Douek, F. Eun‐Hyung Lee, Nadine Rouphael, Alberto Moreno, Benjamin A. Pinsky, Mehul S. Suthar
Abstract
To determine the neutralization efficiency of the booster vaccines against wild-type (WA1/2020) virus and primary isolates of omicron subvariants BA.1, BA.5, BA.2.75.2, BQ.1.1, and XBB.
Topics & Concepts
Bivalent (engine)NeutralizationBooster (rocketry)ChemistryMessenger RNABooster doseMolecular biologyAndrologyVirologyMedicinePhysicsBiologyBiochemistryGeneTiterOrganic chemistryVirusMetalAstronomyViral Infections and Immunology ResearchAnimal Virus Infections StudiesSARS-CoV-2 and COVID-19 Research